Dolby Laboratories, Inc. (DLB)

Dolby Laboratories Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 28, 2025	Sep 27, 2024	Sep 29, 2023	Sep 30, 2022	Sep 24, 2021	Sep 25, 2020
Cash & Equivalents	626.55	482.05	745.36	620.13	1,225	1,072
Short-Term Investments	-	-	139.15	189.21	38.84	46.95
Cash & Short-Term Investments	626.55	482.05	884.51	809.34	1,264	1,119
Cash Growth	-24.09%	-45.50%	9.29%	-35.98%	13.00%	22.10%
Accounts Receivable	544.47	512.94	444.38	419.69	414.93	341.7
Receivables	544.47	512.94	444.38	419.69	414.93	341.7
Inventory	34.59	33.73	35.62	23.55	10.97	25.55
Prepaid Expenses	32.33	29.75	24.44	26.85	29.96	17.88
Restricted Cash	123.79	95.71	72.6	8.24	7.65	8.1
Other Current Assets	27.55	40.25	26.26	23.22	32.77	35.14
Total Current Assets	1,389	1,194	1,488	1,311	1,760	1,547
Property, Plant & Equipment	506.75	518.16	521.78	560.01	601.51	618.48
Long-Term Investments	73.76	89.27	97.81	102.51	62.82	52.15
Goodwill	525.02	533.21	408.41	365.15	340.69	336.95
Other Intangible Assets	412.06	434.51	167.43	112.27	122.89	152.43
Long-Term Deferred Tax Assets	223.41	219.76	201.86	183.57	156.02	118.88
Other Long-Term Assets	98.76	120.61	94.67	55.15	61.26	91.25
Total Assets	3,229	3,110	2,980	2,690	3,106	2,917
Accounts Payable	17.29	17.38	20.93	14.17	17.78	12.62
Accrued Expenses	162.65	171.01	179.01	143.15	157.69	134.31
Current Portion of Leases	10.78	12.24	13.63	13.26	15.4	15.82
Current Income Taxes Payable	13.31	9.05	4.77	1.27	1.33	3.26
Current Unearned Revenue	39.62	31.64	31.51	18.59	18.47	15.44
Other Current Liabilities	213.85	176.52	172.39	87.09	105.03	85.66
Total Current Liabilities	457.49	417.84	422.23	277.52	315.72	267.11
Long-Term Leases	29.66	34.75	37.02	37.69	56.72	65.32
Long-Term Unearned Revenue	29.66	34.59	40	23.2	23.71	24.34
Other Long-Term Liabilities	124.28	130.91	104.04	96	100.43	117.97
Total Liabilities	646.02	623.04	607.58	438.53	501.46	478.92
Common Stock	0.1	0.09	0.09	0.09	0.1	0.1
Retained Earnings	2,602	2,496	2,392	2,298	2,608	2,443
Comprehensive Income & Other	-27.98	-19.19	-36.98	-51.64	-10.03	-10.59
Total Common Equity	2,574	2,477	2,355	2,246	2,598	2,433
Minority Interest	9.35	9.73	17.08	4.84	6.25	5.76
Shareholders' Equity	2,583	2,487	2,372	2,251	2,604	2,438
Total Liabilities & Equity	3,229	3,110	2,980	2,690	3,106	2,917
Total Debt	40.43	46.99	50.65	50.94	72.12	81.14
Net Cash (Debt)	586.12	435.06	833.86	758.4	1,192	1,038
Net Cash Growth	-24.22%	-47.83%	9.95%	-36.38%	14.88%	13.24%
Net Cash Per Share	6.02	4.47	8.53	7.44	11.39	10.08
Filing Date Shares Outstanding	96.07	95.44	95.28	95.96	101.16	100.35
Total Common Shares Outstanding	96.06	95.39	95.76	95.88	101.07	100.3
Working Capital	931.8	776.58	1,066	1,033	1,445	1,280
Book Value Per Share	26.79	25.97	24.59	23.43	25.70	24.25
Tangible Book Value	1,637	1,509	1,779	1,769	2,134	1,943
Tangible Book Value Per Share	17.04	15.82	18.58	18.45	21.12	19.38
Land	41.97	42.01	41.9	41.77	42.04	41.96
Buildings	290.59	288.91	287.8	287.54	284.15	283.62
Machinery	433.31	410.94	418.53	402.9	420.55	389.59
Construction In Progress	26.88	25.09	18.33	23.04	22.92	19.55
Leasehold Improvements	83.11	86.61	79.99	86.79	88.55	83.76

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q